Monday January 27, 2020

HSE’s mounting drug budget needs a shot of strong medicine

Some new treatments cost well over €100,000 per patient, but there are effective ways to rein in expenditure

5th January, 2020

There has been much criticism of the finite drug budget we have in the health service. Last year, even though the HSE invested heavily and funded 29 new medicines, new approvals stalled.

Affordability has become a real issue, even though drug expenditure in Ireland is likely to exceed €2.5 billion in 2019. That represents approximately 17 per cent of total healthcare expenditure in 2019.

Some new drug therapies cost well over €100,000 per patient per year and are frequently...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

The three main parties’ election manifestos are big on promises but short on details when it comes to reforming health, and it’s sure to cause headaches for any incoming government

Susan Mitchell | 1 day ago

Board earmarked funds to enhance claims management and save money over life of project

Peter O'Dwyer | 1 day ago

The genetic data harvesting company posted the results as calls were made for the Irish government to appoint a genomics medicine guru

Killian Woods | 1 day ago